Compare KN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KN | OGN |
|---|---|---|
| Founded | 1946 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.6B |
| IPO Year | 2013 | 2020 |
| Metric | KN | OGN |
|---|---|---|
| Price | $32.89 | $13.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $44.00 | $10.33 |
| AVG Volume (30 Days) | 702.7K | ★ 2.2M |
| Earning Date | 10-22-2026 | 11-13-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ 118.94 | N/A |
| EPS | 0.58 | ★ 1.56 |
| Revenue | $593,200,000.00 | ★ $6,216,000,000.00 |
| Revenue This Year | $16.10 | N/A |
| Revenue Next Year | $8.85 | $2.07 |
| P/E Ratio | $60.14 | ★ $14.52 |
| Revenue Growth | ★ 7.17 | N/A |
| 52 Week Low | $20.57 | $5.69 |
| 52 Week High | $42.93 | $13.83 |
| Indicator | KN | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 64.80 |
| Support Level | $23.97 | $13.72 |
| Resistance Level | $36.54 | $13.83 |
| Average True Range (ATR) | 1.49 | 0.04 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 24.57 | 86.96 |
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.